Beranda › Kanker Paru › New York › Queens
Uji klinis Kanker Paru di Queens, NY
22 studi untuk Kanker Paru mencari peserta di lokasi sekitar Queens (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi jauhnya
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
Menerima pesertaFase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi jauhnya
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Queens Hospital Center, Jamaica · 2 mi jauhnya
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Menerima pesertaFase 3
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauhnya
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Menerima pesertaFase 3
- Optum Medical Care, PC, Westbury · 14 mi jauhnya
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Menerima pesertaFase 2
- MSK Nassau, Uniondale · 13 mi jauhnya
A Registry for People With Lung Cancer
Menerima pesertaStudi observasional
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi jauhnya
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Menerima pesertaFase 2/3
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi jauhnya
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Menerima pesertaFase 1
- NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola · 11 mi jauhnya
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Clinical Research Alliance, Westbury · 14 mi jauhnya
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9 mi jauhnya
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi jauhnya
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Menerima pesertaFase 1
- NYU Langone Health - Long Island, Mineola · 11 mi jauhnya
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Menerima pesertaFase 3
- Northwell Health/R.J. Zuckerberg Cancer Center, Lake Success · 9 mi jauhnya
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Menerima pesertaFase 3
- NYU Langone Hospital - Long Island, Mineola · 11 mi jauhnya
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauhnya
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi jauhnya
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauhnya
A Study of Lung Cancer Risk
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi jauhnya
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Menerima peserta
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre · 10 mi jauhnya
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Menerima pesertaFase 1/2
- Clinical Research Alliance, Westbury · 14 mi jauhnya
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Menerima pesertaFase 2
- Memorial Sloan Kettering Nassau, Rockville Centre · 10 mi jauhnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauhnya
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Menerima pesertaStudi observasional
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi jauhnya
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Hempstead · 12 mi jauhnya
Uji klinis Kanker Paru di kota lain
- Houston, TX78 studi
- Boston, MA62 studi
- New York City, NY60 studi
- Los Angeles, CA45 studi
- Washington, DC41 studi
- Arlington, VA41 studi
- Chicago, IL41 studi
- Nashville, TN40 studi
- Baltimore, MD40 studi
- St. Louis, MO39 studi
- Columbus, OH37 studi
- Philadelphia, PA36 studi
Studi lain di Queens
- Kanker Payudara63 studi
- Kanker Paru Non-Sel Kecil49 studi
- Kanker Kolorektal31 studi
- Kanker Metastatik28 studi
- Kanker Ovarium28 studi
- Kanker Prostat27 studi
- Kanker (semua jenis)26 studi
- Kanker Endometrium25 studi
- Leukemia Mieloid Akut21 studi
- Karsinoma Sel Skuamosa Kepala dan Leher20 studi
- Mieloma Multipel20 studi
- Kanker Pankreas20 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.